Printer Friendly
The Free Library
14,635,740 articles and books
Member login
User name  
Password 
 
Join us Forgot password?

Micronics Appoints Officers and Board Members; Company is Well-positioned for Microfluidics Products and Services Expansion.


Business Editors

REDMOND, Wash.--(BUSINESS WIRE)--Feb. 18, 2002

Micronics, Inc. announced today that it has appointed three new corporate officers and elected three new members to the Board of Directors in support of the company's growth and products and services development strategy.

The Company's Board of Directors has elected Steve Gailar as Chief Executive Officer, and Karen Hedine as President and a director of Micronics. In addition, C. Fred Battrell, Ph.D., has been elected to serve as the company's Vice President of Operations.

Mr. Gailar, a Group Director with Senmed Medical Ventures since 1990, currently serves as Micronics' Chairman of the Board of Directors. Prior to Senmed, he was President and CEO (1) (Chief Executive Officer) The highest individual in command of an organization. Typically the president of the company, the CEO reports to the Chairman of the Board.  of the Marlstone marl·stone  
n.
A rock containing clay materials and calcium and magnesium carbonates, with approximately the same composition as marl.

Noun 1.
 Corporation, a rational drug design firm. Included in his 29 years of healthcare industry experience are 14 years with Eli Lilly Eli Lilly can refer to:
  • Eli Lilly and Company, a global pharmaceutical company
  • Colonel Eli Lilly (1839-1898), founder of Eli Lilly and Company
  • Eli Lilly (industrialist) (1885-1977), former president of Eli Lilly and Company
 in sales, marketing and strategic management assignments. He served as Director of Strategic Planning Strategic planning is an organization's process of defining its strategy, or direction, and making decisions on allocating its resources to pursue this strategy, including its capital and people.  for the pharmaceutical division. He serves on the boards of several privately-held companies.

Ms. Hedine joined Micronics in July 2001, as Vice President of Business Development, and has been instrumental in positioning the company's first products and expanded microfluidics-based lab card and microplumbing development services for clients in the life sciences and drug discovery and development markets. Ms. Hedine has over 15 years of biotech management experience, including corporate financing, merger and acquisition, operations and strategic planning roles. Prior to joining Micronics, she was General Manager of QIAGEN Genomics - the world's first high throughput single nucleotide polymorphism Noun 1. single nucleotide polymorphism - (genetics) genetic variation in a DNA sequence that occurs when a single nucleotide in a genome is altered; SNPs are usually considered to be point mutations that have been evolutionarily successful enough to recur in a  (SNP SNP Scottish National Party

Noun 1. SNP - (genetics) genetic variation in a DNA sequence that occurs when a single nucleotide in a genome is altered; SNPs are usually considered to be point mutations that have been evolutionarily
) genotyping Genotyping refers to the process of determining the genotype of an individual with a biological assay. Current methods of doing this include PCR, DNA sequencing, and hybridization to DNA microarrays or beads.  services facility and a wholly-owned subsidiary of QIAGEN N.V.

Dr. Battrell has been with Micronics since 1999, having previously been with Molecumetics, Ltd, a drug discovery company and wholly-owned subsidiary of Tredegar Corporation as its Vice President of Automated Synthesis for 8 years. Prior to that, Dr. Battrell spent 15 years at Proctor & Gamble in technical strategy and product development roles.

The appointments of Mr. Gailar and Ms. Hedine serve to replace Jim Merselis, former Micronics president/CEO. Mr. Merselis and Mr. Ron Howell have been elected to the company's Board of Directors.

"Jim has a wealth of diagnostics expertise that is of tremendous value to Micronics' future point-of-care lab card business," said Steve Gailar. "This background, combined with Ms. Hedine's and Dr. Battrell's extensive life sciences and drug industry contacts and product development expertise serves to position Micronics for product and client services expansion around our core microfluidics and microplumbing intellectual property and know-how."

"The Company is also pleased to have elected Mr. Ron Howell to the Board of Directors," said Mr. Gailar. "Mr. Howell has served as an observer on the board since 1998, and is the Managing Director of WRF WRF Weather Research and Forecasting (weather forecast model)
WRF Washington Research Foundation
WRF Water Reclamation Facility
WRF World Rehabilitation Fund
WRF World Research Foundation
WRF Winchester Rimfire
 Capital, which invests in Northwest technology-based companies that usually have scientific connections to the University of Washington. WRF Capital is an investor in Micronics."

Micronics, Inc.

Micronics is a leading developer of microfluidics-based solutions. The company's proprietary fluid miniaturization min·i·a·tur·ize  
tr.v. min·i·a·tur·ized, min·i·a·tur·iz·ing, min·i·a·tur·iz·es
To plan or make on a greatly reduced scale.



min
 technologies and products enable faster chemical reactions This is the 18th episode of television drama Men in Trees. It originally aired on June 25, 2007 on the TV2 network in New Zealand as a continuation of season 1. Recap
Marin and Cash have a stew cook off, she admits his is better than hers.
 of complex fluids at consider able cost, labor and time savings. Micronics' unique technology platforms allow lab-on-a-chip sample preparation, chemical separation and analysis, miniaturized cellular analysis, and the analysis of whole blood. Visit www.micronics.net for more information on Micronics' microfluidics technologies, products and services.
COPYRIGHT 2002 Business Wire
No portion of this article can be reproduced without the express written permission from the copyright holder.
Copyright 2002, Gale Group. All rights reserved. Gale Group is a Thomson Corporation Company.

 Reader Opinion

Title:

Comment:



 

Article Details
Printer friendly Cite/link Email Feedback
Publication:Business Wire
Date:Feb 18, 2002
Words:537
Previous Article:IPNet Unveils Second Generation E-Business Product Line.
Next Article:GITWiT Changes Name To Wildseed, Unveils Wireless Solution for the Youth Market at 3GSM World Congress.



Related Articles
Executives.
Micronics, Inc. Announces Relocation and Expansion.
Mathies and Crawford Named to Micronics Scientific Advisory Board.
Pierce and Micronics Announce Distribution Agreement for Microfluidic Evaluation Kit; Enables Lab-on-a-Chip Evaluation for Range of Chemical...
Corporate Profile for Micronics, Inc., dated September 21, 2001.
Micronics and Renal Plant Enter Agreement to Develop Artificial Kidney Microfluidic Lab-On-A-Chip Platform for Kidney Hemodialysis.
Micronics and Honeywell Enter Microfluidic Technologies Co-Promotion Agreement; Unique Solutions Brought Together for Product Applications.
Stratos Forms Alliance with Micronics; Companies Offer Combined Capabilities from Technological Innovation to Commercial Product Launch.
Micronics and CFD Research Corporation Form Co-Marketing Alliance; Fluid modeling software enables lab-on-a-card applications.
Casio Micronics Develops Next-generation Chip-on-film.

Terms of use | Copyright © 2009 Farlex, Inc. | Feedback | For webmasters | Submit articles